Status:
COMPLETED
To Explore the Efficacy and Safety of Surgical Treatment for Constipation, as Well as the Changes of Postoperative Intestinal Motility, Flora, Nutritional Status and Other Indicators
Lead Sponsor:
Shanghai 10th People's Hospital
Conditions:
Constipation
Surgical Treatment
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Chronic constipation is a heterogeneous disease with multiple symptoms, and its incidence is on the rise in many countries. It has become a common disease affecting the quality of life. When these pat...
Eligibility Criteria
Inclusion
- Disease duration more than 6 years;
- Wexner constipation score \>15;
- No response to medical treatment, biofeedback and fecal microbiota transplantation;
- according to the surgical indications;
- All patients were informed of this study and signed the informed consent.
Exclusion
- Suffering from mental disorders or cognitive impairment;
- With malignant tumors; -
- With history of gastrointestinal surgery;
- Complicated with other organ dysfunction;
- With immune system diseases.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05983926
Start Date
January 1 2020
End Date
June 30 2024
Last Update
July 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China, 200071